VistaPharm LLC: Drug Recall
Recall #D-1149-2023 · 08/30/2023
Class II: Risk
Recall Details
- Recall Number
- D-1149-2023
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- VistaPharm LLC
- Status
- Terminated
- Date Initiated
- 08/30/2023
- Location
- Largo, FL, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 14,400 bottles
Reason for Recall
Superpotent/Subpotent single ingredient Drug: Out of Specification Assay results
Product Description
Sucralfate Oral Suspension 1g per 10mL, FOR ORAL ADMINISTRATION ONLY (414 mL bottle), Rx Only, Manufactured and Distributed by: VistaPharm, Inc. Largo, FL 33771, NDC 66689-305-16
Distribution Pattern
Distributed nationwide to 68 consignees in the U.S.
Other Recalls by VistaPharm LLC
- Class III: Low Risk 10/26/2023
- Class I: Dangerous 10/18/2023
- Class III: Low Risk 10/17/2023
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.